European Journal of Surgical Oncology
Volume 32, Issue 7 , Pages 738-742 , September 2006

Experience with intradermal injection and intradermal-plus-deep injection in the radioguided sentinel node biopsy of early breast cancer patients

  • M. Koizumi

      Affiliations

    • Department of Nuclear Medicine, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan
    • Corresponding Author InformationCorresponding author. Department of Nuclear Medicine, Cancer Institute Hospital, Tokyo, Japan. Tel.: +81 3 3570 0205; fax: +81 3 3570 0204.
    • ,
  • M. Koyama

      Affiliations

    • Department of Nuclear Medicine, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan
    • ,
  • T. Yamashita

      Affiliations

    • Department of Nuclear Medicine, Cancer Institute Hospital, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan
    • ,
  • K.-I. Tada

      Affiliations

    • Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
    • ,
  • S.-I. Nishimura

      Affiliations

    • Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
    • ,
  • K. Takahashi

      Affiliations

    • Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
    • ,
  • M. Makita

      Affiliations

    • Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
    • ,
  • T. Iwase

      Affiliations

    • Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
    • ,
  • M. Yoshimoto

      Affiliations

    • Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
    • ,
  • F. Kasumi

      Affiliations

    • Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan

,Accepted 20 April 2006.

References 

  1. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer. N Engl J Med. 1998;339:941–946
  2. Borgstein PJ, Meijer S, Pijpers RJ, van Diest PJ. Functional lymphatic anatomy for sentinel node biopsy in breast cancer. Ann Surg. 2000;232:81–89
  3. Veronessi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–553
  4. Edge SB, Niland JC, Bookman MA, et al. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst. 2003;95:1514–1521
  5. Krynckyi BR, Kim CK, Shafir MK, Mosci K, Machac J. Breast cancer and its management: The utility and technique of lymphoscintigraphy. In:  Freeman LM editors. Nuclear medicine annual 2003. Philadelphia: Lippincott Williams and Wilkins; 2003;p. 131–169
  6. Nieweg OE, Estourgie SH, Van Rijk MC, Kroon BBR. Rationale for superficial injection techniques in lymphatic mapping in breast cancer patients. J Surg Oncol. 2004;87:153–156
  7. Roumen RM, Geuskens LM, Valkenberg JG. In search of true sentinel node by different injection techniques in breast cancer patients. Eur J Surg Oncol. 1999;25:347–351
  8. Krynyckyi BR, Chun H, Kim HH, Eskandar Y, Kim CK, Machac J. Factors affecting visualization rates of internal mammary sentinel nodes during lymphoscintigraphy. J Nucl Med. 2003;44:1387–1393
  9. Turner-Warwick RT. The lymphatics of the breast. Br J Surg. 1959;46:574–582
  10. Auchincloss H. Significance of location and number of axillary metastasis in carcinoma of the breast: A justification for conservative operation. Ann Surg. 1963;158:37–46
  11. Mariani G, Moresco L, Viale G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med. 2001;42:1198–1215
  12. Koizumi M, Nomura E, Yamada Y, et al. Radio-guided sentinel node detection in breast cancer patients: comparison between Tc-99m phytate and Tc-99m rhenium colloid. Nuclear Med Commun. 2004;25:1031–1037
  13. Maza S, Valencia R, Geworski L, et al. Peritumoral versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study. Eur J Nucl Med Mol Imaging. 2003;30:651–656
  14. Kimberg VS, Rubio IT, Henry R, Cowan C, Colvert M, Korourian S. Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg. 1999;229:860–864
  15. Borgstein PJ, Meijer S, Pjipers R. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet. 1997;349:1668–1669
  16. Estourgie SH, Nieweg OE, Olmos RAV, Rutgers EJT, Kroon BBR. Lymphatic drainage patterns from the breast. Ann Surg. 2004;239:232–237
  17. Sugg SL, Ferguson DJ, Posner MC, Heimann R. Should internal mammary nodes be sampled in the sentinel lymph node era?. Ann Surg Oncol. 2000;7:188–192
  18. Van der Ent FWC, Kengen RA, Van der Pol HAG, Povel JACM, Stroeken HJG, Hoofwijk AGM. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg. 2001;234:79–84
  19. Tavares MGM, Sapienza MT, Galeb NA, et al. The use of Tc-99m phytate for sentinel node mapping in melanoma, breast cancer and vulvar cancer: a study of 100 cases. Eur J Nucl Med. 2001;28:1597–1604

PII: S0748-7983(06)00179-X

doi: 10.1016/j.ejso.2006.04.015

European Journal of Surgical Oncology
Volume 32, Issue 7 , Pages 738-742 , September 2006

Article Tools